AngioDynamics Executive and Leadership Team

Yoel Zabar, the Chief Executive Officer at AngioDynamics, directs the company's overall strategic vision and operational execution. Zabar guides AngioDynamics' mission to develop high-quality medical devices that enhance patient outcomes, leveraging the company's established global presence. This leadership role involves steering the organization through market dynamics and fostering innovation within the medical community. By ensuring alignment with the companys core values, Yoel Zabar drives AngioDynamics' commitment to advancing healthcare solutions across key markets worldwide. The Chief Executive Officer's oversight extends to cultivating strategic partnerships and expanding distribution networks to solidify the companys market position and contribute to improved patient care on a global scale.

Robert Palladino, the Chief Financial Officer at AngioDynamics, manages the companys financial strategy and fiscal operations. Palladino oversees all aspects of financial planning, reporting, and investment, ensuring the companys fiscal health and supporting its growth initiatives. This critical role involves optimizing resource allocation to drive the development of innovative medical devices and maintain AngioDynamics' global operational capacity. By providing financial leadership, Robert Palladino supports the companys commitment to improving patient outcomes through high-quality medical solutions. The Chief Financial Officer's responsibilities include managing capital, assessing financial risks, and ensuring compliance with all relevant financial regulations, thereby underpinning the companys market presence and strategic partnerships.

Sibabalo Sibabalo, the Group Chief Financial Officer at AngioDynamics, oversees the financial architecture and performance across the companys global operations. Sibabalo directs the financial reporting and management for all international divisions, ensuring fiscal integrity and strategic alignment with the companys overarching mission. This position is vital for managing the financial complexities associated with AngioDynamics' worldwide presence and its commitment to advancing medical device innovation. By guiding financial strategies, Sibabalo Sibabalo supports the companys objective of improving patient outcomes through high-quality medical solutions. The Group Chief Financial Officer's scope includes optimizing financial structures, managing international investments, and ensuring robust financial controls to sustain AngioDynamics' strong position in key healthcare markets.

Stephen Trowbridge, the Executive Vice President & Chief Financial Officer at AngioDynamics, directs the companys comprehensive financial planning and management. Trowbridge oversees fiscal operations, ensuring robust financial controls and strategic resource allocation to support AngioDynamics' innovation in medical device development. This leadership position is crucial for maintaining the companys financial stability and enabling its global expansion efforts. By guiding financial strategies, Stephen Trowbridge reinforces AngioDynamics' dedication to improving patient outcomes through high-quality medical solutions. The Executive Vice President & Chief Financial Officer's responsibilities encompass financial reporting, risk management, and capital deployment, all vital for sustaining the companys strong presence in key healthcare markets and fostering strategic partnerships worldwide.

Marna Bronfen-Moore, the Senior Vice President, Chief Human Resources Officer at AngioDynamics, leads all human capital strategies and organizational development initiatives. Bronfen-Moore shapes the companys culture, ensuring a supportive environment that fosters innovation and collaboration among employees worldwide. This role is essential for attracting, retaining, and developing the talent necessary to drive AngioDynamics' mission of creating high-quality medical devices that improve patient outcomes. By managing HR operations globally, Marna Bronfen-Moore supports the companys commitment to its workforce and its strategic partnerships. The Chief Human Resources Officer's focus includes implementing effective HR policies, overseeing talent management, and ensuring employee engagement across AngioDynamics' international operations, thereby contributing to the companys sustained growth and market leadership.

Larry Weiss, the Chief Legal Officer & Corporate Secretary at AngioDynamics, provides strategic legal counsel and oversees all corporate governance matters. Weiss ensures compliance with legal and regulatory frameworks across AngioDynamics' global operations, safeguarding the company's interests and upholding its ethical standards. This role is fundamental to supporting the development and distribution of high-quality medical devices that enhance patient outcomes. By managing legal affairs, Larry Weiss facilitates AngioDynamics' strategic partnerships and its worldwide market presence. The Chief Legal Officer & Corporate Secretary's purview includes managing litigation, advising on corporate transactions, and maintaining corporate records, all critical for the company's sustained success and commitment to advancing healthcare solutions.